Descripción

Experimental design for investigating mineralocorticoid receptor pathway blockade against SARS-CoV-2 Spike protein-induced endothelial inflammation in human aortic endothelial cells is outlined.

Figure 1

Diagram

Source Paper

Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein.

Biomedicines (2021)

PMID: 34204890

DOI: 10.3390/biomedicines9060639

Cite This Figure

![Figure 1: Experimental design for investigating mineralocorticoid receptor pathway blockade against SARS-CoV-2 Spike protein-induced endothelial inflammation in human aortic endothelial cells is outlined.]()

> Source: Eva Jover et al. "Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endoth." *Biomedicines*, 2021. PMID: [34204890](https://pubmed.ncbi.nlm.nih.gov/34204890/)

<figure>
  <img src="" alt="Experimental design for investigating mineralocorticoid receptor pathway blockade against SARS-CoV-2 Spike protein-induced endothelial inflammation in human aortic endothelial cells is outlined." />
  <figcaption>Figure 1. Experimental design for investigating mineralocorticoid receptor pathway blockade against SARS-CoV-2 Spike protein-induced endothelial inflammation in human aortic endothelial cells is outlined.<br>  Source: Eva Jover et al. "Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endoth." <em>Biomedicines</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34204890/">34204890</a></figcaption>
</figure>

Evidencia relacionada

Iron para Pediatric Immune Support

Calificación C · 5 estudios